Groowe Groowe / Newsroom / DRMA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

DRMA News

Dermata Therapeutics, Inc. Common Stock

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025

accessnewswire.com
DRMA

Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing

accessnewswire.com
DRMA DRMAW

Dermata Opens a New Chapter with the Release of Tome Skincare

accessnewswire.com
DRMA DRMAW

Form 8-K

sec.gov
DRMA DRMAW

Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office

accessnewswire.com
DRMA DRMAW

Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

accessnewswire.com
DRMA DRMAW

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

accessnewswire.com
DRMA DRMAW

A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity

accessnewswire.com
DRMA DRMAW

Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results

accessnewswire.com
DRMA

Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office

accessnewswire.com
DRMA DRMAW